Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

Journal of Clinical Investigation

Volumn 103, Issue 6, 1999, Pages 807-815

  Sørensen, Torben L ^a,b   Tani, Marie ^a   Jensen, Jakob ^b   Pierce, Virginia ^a   Lucchinetti, Claudia ^c   Folcik, Virginia A ^a   Qin, Shixin ^d   Rottman, Jim ^d   Sellebjerg, Finn ^b   Strieter, Robert M ^e   Frederiksen, Jette L ^b   Ransohoff, Richard M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c MAYO CLINIC   (United States)

^d MILLENNIUM PHARMACEUTICALS INC   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; MONOKINE; RANTES;

ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEMYELINATING DISEASE; HUMAN; INFLAMMATORY INFILTRATE; LYMPHOCYTE; MACROPHAGE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033559346     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5150     Document Type: Article

References (79)

1. Trapp, B., et al. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:278-290.
2. Rudick, R, Cohen, J., Weinstock-Guttman, B., Kinkel, R., and Ransohoff, R. 1996. Management of multiple sclerosis. N. Engl. J. Med. 337:1604-1612.
3. Sørensen, T., and Ransohoff, R 1998. Etiology and pathogenesis of multiple sclerosis. Semin. Neurol. 18:287-295.
4. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:299-302.
5. Rudick, R., et al. 1999. Cerebrospinal fluid abnormalities in a phase III trial of avonex (IFNB-1a) for relapsing multiple sclerosis. J. Neuroimmunol. 93:8-15.
6. Cannella, B., Cross, A.H., and Raine, C.S. 1993. Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 46:43-56.
7. Antel, J., and Owens, T. 1993. The attraction of adhesion molecules. Ann. Neurol. 34:123-124.
8. Yednock, T.A., et al. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha4betal integrin. Nature. 356:63-66.
9. Engelhardt, B., Conley, F.K., Kilshaw, P.J., and Butcher, E.C. 1995. Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1. Int. Immunol. 7:481-491.
10. Butcher, E.C., and Picker, L.J. 1996. Lymphocyte homing and homeostasis. Science. 272:60-66.
11. Luster, A. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Eng. J. Med. 338:436-445.
12. Rollins, B.J. 1997. Chemokines. Blood. 90:909-928.
13. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature. 392:565-568.
14. Campbell, J.J., et al. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science. 279:381-384.
15. Lira, S., Fuentes, M., Strieter, R., and Durham, S. 1997. Transgenic methods to study chemokine function in lung and central nervous system. Methods Enzymol. 287:304-318.
16. Tani, M., et al. 1996. Neutrophil infiltration, glial reaction and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. J. Clin. Invest. 98:529-539.
17. Bell, M.D., et al. 1996. Recombinant human adenovirus with rat MIP-2 gene insertion causes prolonged PMN recruitment to the murine brain. Eur. J. Neurosci. 8:1803-1811.
18. Fuentes, M., et al. 1995. Controlled recruitment of monocytes/macrophages to specific organs via transgenic expression of MCP-1. J. Immunol. 155:5769-5776.
19. Ransohoff, R., Glabinski, A., and Tani, M. 1996. Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev. 7:35-46.
20. Karpus, W., and Ransohoff, R. 1998. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis [comment]. J. Immunol. 161:2667-2671.
21. Karpus, W.J., et al. 1995. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of rhe T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:5003-5010.
22. Karpus, W.J., and Kennedy, K.J. 1997. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leukoc. Biol. 62:681-687.
23. Berman, J., Guida, M., Warren, J., Amat J., and Brosnan, C. 1996. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 156:3017-3023.
24. Godiska, R., Chantry, D., Dietsch, G.N., and Gray, P.W. 1995. Chemokine expression in murine expenmental allergic encephalomyelitis. J. Neuroimmunol. 58:167-176.
25. Glabinski, A., Tani, M., Strieter, R., Tuohy, V., and Ransohoff, R. 1997. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of experimental autoimmune encephalomyelitis. Am. J. Pathol. 150:617-630.
26. Glabinski, A., Tani, M., Tuohy, V.K., Tuthill, R., and Ransohoff, R.M. 1996. Central nervous system chemokine gene expression follows leukocyte entry in acute murine experimental autoimmune encephalomyelitis. Brain Behav. Immun. 9:315-330.
27. Hulkower, K., et al. 1993. Impression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J. Immunol. 150:2525-2533.
28. Miyagishi, R., Kikuchi, S., Takayama, C., Inoue, Y., and Tashiro, K. 1997. Identification of cell types producing RANTES, MIP-1α and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridization. J. Neuroimmunol. 77:17-26.
29. Tani, M., et al. 1996. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am. J. Pathol. 148:889-896.
30. Tani, M., and Ransohoff, R.M. 1994. Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma? Brain Pathol. 4:135-144.
31. Glabinski, A.R., Tani, M., Balasingam, V., Yong, V.W., and Ransohoff, R.M. 1996. Chemokine monocyte chemoattractant protein-1 (MCP-I) is expressed by astrocytes after mechanical injury to the brain. J. Immunol. 156:4363-436.
32. Grzybicki, D., et al. 1998. Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma. Acta Neuropathol. 95:98-103.
33. Liu, T., et al. 1993. Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci Lett. 164:125-128.
34. McTigue, D., et al. 1998. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J. Neurosci. Res. 53:368-376.
35. Ransohoff, R., and Tani, M. 1998 Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation? Trends Neurosci. 21:154-159.
36. Gourmala, N.G., Buttini, M., Limonta, S., Sauter, A., and Boddeke, H.W. 1997. Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration. J. Neuroimmunol. 74:35-44.
37. Hvas, J., et al. 1997. Perivascular T cells express the proinflammatory chemokine RANTES mRNA in multiple sclerosis lesions. Scand. J. Immunol. 46:195-203.
38. McManus, C., et al. 1998. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study, J. Neuroimmunol 86:20-29.
39. Simpson, J., Newcombe, J., Cuzner, M., and Woodroofe, M. 1998. Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol. 84:238-249.
40. Miyagishi, R., Kikuchi, S., Fukazawa, T., and Tashiro, K. 1995. Macrophage inflammatory protein-1α in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J. Neurol. Sci. 129:223-227.
41. Poser, C.M., et al. 1983. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:227-231.
42. Francis, D.A. 1991. Demyelinating optic neuritis: clinical features and differential diagnosis. Br. J. Hosp. Med. 45:376-379.
43. McDonald, W.I. 1976. Diagnosis and management of optic neuritis. Trans. Ophtalmol. Soc. NZ. 28:11-17.
44. Frederiksen, J.L., Larsson, H.B., and Jensen, C. 1997. Serial gadolinium-enhanced MRI in untreated patients with acute optic neuritis: implications for natural history. Acta Neurol. Scand. 96:22-27.
45. Sellebjerg, F., and Christiansen, M. 1996. Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement. Scand. J. Clin. Lab. Invest. 56:135-143.
46. Verma, M.J., et al. 1997. Chemokines in acute anterior uveitis. Curr. Eye Res. 16:1202-1208.
47. Lassmann, H., Raine, C., Antel, J., and Prineas, J. 1998. Immunopathology of multiple sclerosis. J. Neuroimmunol 86:213-218.
48. Qin, S., et al. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:746-754.
49. Vallat, A.V., et al. 1998. Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am. J. Pathol. 152:167-178.
50. Sasseville, V.G., et al. 1996. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am. J. Pathol. 149:1459-1467.
51. Morgan, J., Navabi, H., Schmid, K., and Jasani, B. 1994. Possible role of tissue-bound calcium ions in citrate-mediated high-temperature antigen retrieval. J. Pathol. 174:301-307.
52. Sellebjerg, F., Jensen, J., and Ryder, L.P. 1998. Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis. J. Neuroimmunol. 84:179-187.
53. Loetscher, M., et al. 1996. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:963-969.
54. Farber, J.M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61:246-257.
55. Ransohoff, R.M., et al. 1993. Astrocyte expression of mRNA encoding cyrokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:592-602.
56. Loetscher, P., et al. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature. 391:344-345.
57. Sallusto, F., Lenig, D., Mackay, C.R., and Lanzavecchia, A. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875-883.
58. Su, S.B., Mukaida, N., Wang, J., Nomura, H., and Matsushima, K. 1996. Preparation of specific polyclonal antibodies to a C-C chemokine receptor, CCR1, and determination of CCR1 expression on various types of leukocytes. J. Leukoc. Biol 60:658-666.
59. Sallusto, F., Mackay, C.R., and Lanzavecchia, A. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 277:2005-2007.
60. Vrethem, M., et al. 1998. CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls. Acta Neurol. Scand. 97:215-220.
61. Lahrtz, F., et al. 1997. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protem-10 and monocyte chemotactic protein-1. Eur. J. Immunol. 27:2484-2489.
62. Weller, R. 1998. Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, priori disorders and multiple sclerosis. J. Neuropathol. Exp. Neurol. 57:885-894.
63. Sprenger, H., et al. 1996. Chemokines in the cerebrospinal fluid of patients with meningitis. Clin. Immunol. Immunopathol. 80:155-161.
64. Ostergaard, C., et al. 1996. Interleukin-8 in cerebrospinal fluid from patients with septic and aseptic meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 15:166-169.
65. Spanaus, K.S., et al. 1997. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J. Immunol. 158:1956-1964.
66. Conant, K., et al. 1998. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA. 95:3117-3121.
67. Calabresi, P.A., et al. 1998. ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions. J. Neuroimmunol. 85:212-219.
68. Olsson, T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:245-268.
69. Rollins, B., Yoshimura, T., Leonard, E., and Pober, J. 1990. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am. J. Pathol. 136:1229-1233.
70. Lu, B., et al. 1998. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187:601-608
71. Karpus, W., et al. 1997. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol 158:4129-4136.
72. Bonecchi, R., et al. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129-134.
73. Bennetts, B.H., Teutsch, S.M., Buhler, M.M., Heard, R.N., and Stewart, G.J. 1997. The CCR5 deletion mutation fails to protect against multiple sclerosis. Hum. Immunol. 58:52-59.
74. Wojcik, W.J., Swoveland, P., Zhang, X., and Vanguri, P. 1996. Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of Lewis rat. J. Pharmacol. Exp. Ther. 278:404-410.
75. Sriram, S., and Rodriguez, M. 1997. Indictment of the microglia as the villain in multiple sclerosis. Neurology. 48:464-470.
76. Lucchinetti, C.F., Bruck, W., Rodriguez, M., and Lassmann, H. 1996. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol. 6:259-274
77. Rottman, J.B., et al. 1997. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 151:1341-1351.
78. Zhou, V., et al. 1998. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160:4018-4026.
79. Meucci, O., et al. 1998. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA. 95:14500-14505.